Trial intelligence / Profile preview

Oxymorphone ER in Opioid-Naïve Chronic Low Back Pain

NCT00225797Phase 3Completed

Sponsor
Endo International plc
Start
Nov 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of oxymorphone in chronic low back pain (CLBP), sponsored by Endo International plc. Started Nov 2004; status: completed.

02

Drugs

oxymorphone
03

Conditions

chronic low back pain (CLBP)

Beyond the preview

Go deeper on NCT00225797.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00225797.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call